Germany· DE-A57-7604e8bbc58ca3bc
Silkis
A calcitriol product containing calcitriol, registered in Germany by Kohlpharma Gmbh. The same ATC class is registered in 7 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Calcitriol is registered in 7 of 19 countries.
Countries holding a registration under ATC D05AX03 (calcitriol), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 2 of them publish a price we can compare per daily dose
Calcitriol · ATC D05AX03
7 / 19 countries
- Canada
- Finlandprice
- Germany
- Ireland
- Netherlands
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of calcitriol costs, country by country.
Normalised to the WHO defined daily dose (6 mcg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Calcitriol · price per daily dose (6 mcg)
USD · FX 28 Sept 2026
- ES Spain$5.53
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Calcitriol
- Manufacturer
- Kohlpharma Gmbh
- Country
- Germany (DE)
- ATC code
- D05AX03
- ATC class
- Calcitriol
- Defined daily dose
- 6 mcg, T
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
54 interactions on record for calcitriol.
Graded by severity as the source publishes them — 54 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Calcitriol · interactions on record
54 records
- 54 moderate
Most severe, free to view
- Calcium carbonateA02AC01moderate
- ErgocalciferolA11CC01moderate
- DihydrotachysterolA11CC02moderate
- ColecalciferolA11CC05moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under D05AX03
Calcitriol, as other registers publish it.
- United StatescalcitriolPadagis Israel Pharmaceuticals Ltd
- FinlandSilkisParanova Oy
- FinlandSilkisGalderma Nordic AB
- CanadaSILKISGALDERMA CANADA INC
- IrelandSilkis 3 micrograms per g ointmentGalderma International
- United KingdomSilkis ointmentGalderma (UK) Ltd
- United KingdomSilkis ointmentNecessity Supplies Ltd
- United KingdomSilkis ointmentDE Pharmaceuticals
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/890ccfaf-e2d3-4a83-8c15-f75383ed53f9 GET /v1/drugs/890ccfaf-e2d3-4a83-8c15-f75383ed53f9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Cutaneous Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Calcitriol",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about calcitriol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.